GFI releases most-traded CDS list

Interdealer broker GFI has released its monthly report on the most actively traded US, European and Asian names in the credit default swap (CDS) market in September.

In the US, the motor industry was most active, with Ford and General Motors among the most commonly traded names. Nashville-based healthcare firm HCA was the only non-motoring sector CDS in the most-active column. In Europe, fixed-line telecoms dominated the list, including Telecom Italia, Portugal Telecom International Finance and Deutsche Telekom. French auto manufacturer Valeo also pushed the European motoring industry into the most-active column for the first time since July 2005.

In Asia, the financial services sector was the most active for the fifth month in a row, led by Kyoto-based Aiful. Nippon Steel was the second most active CDS, while trading companies, banks and electrical equipment firms were also active.

Meanwhile, the three most active sovereign CDSs were linked to the governments of Turkey, Brazil and Venezuela, followed by the Philippines and Hungary.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Chartis Energy50 2023

The latest iteration of Chartis' Energy50 2023 ranking and report considers the key issues in today’s energy space, and assesses the vendors operating within it

2021 brings big changes to the carbon market landscape

ZE PowerGroup Inc. explores how newly launched emissions trading systems, recently established task forces, upcoming initiatives and the new US President, Joe Biden, and his administration can further the drive towards tackling the climate crisis

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here